SEC 13F Intelligence

Sivik Global Healthcare LLC / DGX

Sivik Global Healthcare LLC’s Quest Diagnostics Inc Position

Does Sivik Global Healthcare LLC own Quest Diagnostics Inc (DGX)? Not currently — the last reported position was 20.0K shares worth $4M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q3 2025
Shares
20.0K
% of Portfolio
+1.11%
Quarters Held
9
position exited

Position History DGX

Reported value by quarter
Q2 ’19: $3MQ2 ’19Q3 ’19: $5MQ4 ’19: $3MQ4 ’19Q2 ’20: $14MQ3 ’20: $6MQ3 ’20Q3 ’21: $4MQ4 ’23: $4MQ4 ’23Q2 ’25: $4MQ3 ’25: $4MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202520.0K$4M+1.11%
Q2 202525.0K$4M+1.22%
Q4 202330.0K$4M+1.73%
Q3 20216.0K$4M+0.87%
Q3 202050.0K$6M+2.46%
Q2 2020125.0K$14M+4.72%
Q4 201927.5K$3M+1.09%
Q3 201950.0K$5M+2.70%
Q2 201930.0K$3M+0.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of DGX.